Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma

Ahmet Sarici, Soykan Bicim, Mehmet Ali Erkurt, Ilhami Berber, Emin Kaya, Irfan Kuku, Mustafa Ozgul.




Abstract
Cited by 0 Articles

The Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus detected in the Wuhan Province of the People's Republic of China caused a pandemic in a very short time all over the world.
Convalescent plasma (CP) therapy is a passive antibody therapy that has been shown to be effective in epidemic periods. CP therapy has been of interest in the treatment of infection with no vaccine or specific treatment, such as the Sars-CoV-2 infection that causes COVID-19.
We aimed to report our CP experience in Sars-Cov-2 infection in our relapsed / refractory Multiple myeloma (MM) patient.

Key words: Comorbidity; Convalescent plasma; immunocompromised patient; multiple myeloma; SARS-CoV-2 infection






Full-text options


Share this Article


Online Article Submission
• ejmanager.com


ejPort - eJManager.com
Refer & Earn
JournalList
 About BiblioMed
License Information
Terms & Conditions
Privacy Policy
 Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.